Identifying the Most Cost-Effective Way to Large Scale Vaccination in Rural Bangladesh

How to cite

Islam, Asad; Kim, Hyuncheol; Prakashi, Debayan; Sim, Armand; Arora, Dinesh; Chen, Dai-Ling; Raitzer, David A.; Bhutani, Piyush; Mohan, Diwakar; Shimul, Shafiun. 2022. "Identifying the Most Cost-Effective Way to Large Scale Vaccination in Rural Bangladesh." AEA RCT Registry. AEARCTR-0008273. https://doi.org/10.1257/rct.8273-1.1

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Asad Islam* , Hyuncheol Kim , Debayan Prakashi , Armand Sim , Dinesh Arora , Dai-Ling Chen , David A. Raitzer , Piyush Bhutani , Diwakar Mohan , Shafiun Shimul

* Primary investigator

Registry ID
AEARCTR-0008273
DOI
https://doi.org/10.1257/rct.8273-1.1
First registered
Last updated
Status
In development
Trial dates
2022-02-01 – 2023-06-30
Countries
Private
JEL codes
I1, I12, I18, I20, I3
Registry record
http://www.socialscienceregistry.org/trials/8273

Abstract

Increasing COVID-19 vaccination uptake is crucial for controlling the spread of COVID-19, economic recovery, and returning to normal or near-normal daily lives. However, even when supplies are increasingly available, COVID-19 vaccine take-up rates in many countries are still low owing to widespread vaccine hesitancy. We conduct a randomized controlled trial with individuals in rural Bangladesh to understand the barriers to vaccine take-up and identify the most effective way to increase it. We test several strategies: information about the benefits and risk about COVID-19 vaccines, information and accessibility assistance, and information and campaign by local eminent individuals.

Intervention

We conduct a cluster randomized experiment that varies treatments at the village level. All treatment groups receive information about COVID-19 vaccines. In total, we have three treatment groups--information only, information and accessibility, and information and campaign by local eminent individuals--and one control group. All participants in treatment groups will receive a set of information about benefits of COVID-19 vaccines, availability of vaccines, distribution of infection and fatality rates, among others delivered by field workers verbally. Information was collected from the WHO, Bangladeshi health ministry, and local governments. Individuals in (information and) accessibility group will receive assistance on registration/enrollment and transportation. Individuals in (information and) local eminent individuals group will receive encouragement from local eminent individuals that we recruited. Control group does not receive any information treatment.

Experimental design

We will randomly assign 9,000 individuals aged 18+ (one from each household) randomly selected from 685 different locations (both rural and urban) across several districts in Bangladesh to one of the three treatments and one control group.

Design details

Randomization method
Randomization will be done by a computer (using STATA).
Randomization unit
Randomization will be done at the community level.
Clusters
600 locations.
Observations
12,000 eligible individuals (one from each household).
Arms
685 locations (and 9,000 individuals) will be randomly assigned to the three treatments and one control group.
Primary outcomes
Vaccination decisions (first and second dose) 1. Vaccination uptake 2. Vaccination intention: willingness to get vaccinated
Secondary outcomes
1. Compliance to COVID-19 health protocols 2. Post-intervention COVID infection 3. Mental health: general mental health status and mental health status attributed to COVID-19 4. Knowledge and beliefs about COVID-19 and vaccines

Cited by

No citation data available for this registration yet.

Keywords